Comprehensive molecular characterization of cancer-associated mutations has identified alterations in the Hippo cascade and its effectors YAP and TAZ as dominant oncogenic drivers in a variety of malignancies, including HNSCC [15]. The gene discussed is WWTR1; the disease is cancer.